Jane Street’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $705K | Sell |
257,200
-545,900
| -68% | -$1.73M | ﹤0.01% | 7264 |
|
|
2025
Q4 | $2.97M | Buy |
803,100
+665,100
| +482% | +$2.15M | ﹤0.01% | 4055 |
|
|
2025
Q3 | $366K | Buy |
138,000
+95,600
| +225% | +$185K | ﹤0.01% | 8519 |
|
|
2025
Q2 | $41.7K | Buy |
+42,400
| New | +$42.5K | ﹤0.01% | 9216 |
|
|
2025
Q1 | – | Sell |
-253,000
| Closed | -$557K | – | 9707 |
|
|
2024
Q4 | $557K | Buy |
253,000
+218,600
| +635% | +$510K | ﹤0.01% | 6569 |
|
|
2024
Q3 | $56.8K | Sell |
34,400
-6,600
| -16% | -$13.3K | ﹤0.01% | 9149 |
|
|
2024
Q2 | $91K | Sell |
41,000
-3,300
| -7% | -$7.76K | ﹤0.01% | 8764 |
|
|
2024
Q1 | $119K | Sell |
44,300
-93,500
| -68% | -$227K | ﹤0.01% | 8465 |
|
|
2023
Q4 | $412K | Buy |
+137,800
| New | +$179K | ﹤0.01% | 7102 |
|
|
2023
Q3 | – | Sell |
-12,100
| Closed | -$16.8K | – | 8815 |
|
|
2023
Q2 | $16.8K | Sell |
12,100
-83,200
| -87% | -$116K | ﹤0.01% | 8375 |
|
|
2023
Q1 | $152K | Sell |
95,300
-62,200
| -39% | -$321K | ﹤0.01% | 8008 |
|
|
2022
Q4 | $981K | Sell |
157,500
-4,900
| -3% | -$35K | ﹤0.01% | 5013 |
|
|
2022
Q3 | $1.09M | Buy |
162,400
+48,800
| +43% | +$335K | ﹤0.01% | 5264 |
|
|
2022
Q2 | $722K | Buy |
113,600
+23,300
| +26% | +$132K | ﹤0.01% | 6073 |
|
|
2022
Q1 | $419K | Buy |
90,300
+35,500
| +65% | +$152K | ﹤0.01% | 7806 |
|
|
2021
Q4 | $274K | Buy |
54,800
+27,300
| +99% | +$219K | ﹤0.01% | 8343 |
|
|
2021
Q3 | $331K | Buy |
27,500
+12,600
| +85% | +$183K | ﹤0.01% | 7997 |
|
|
2021
Q2 | $315K | Buy |
14,900
+4,100
| +38% | +$98.7K | ﹤0.01% | 8058 |
|
|
2021
Q1 | $303K | Sell |
10,800
-85,100
| -89% | -$2.51M | ﹤0.01% | 7695 |
|
|
2020
Q4 | $2.49M | Buy |
95,900
+22,200
| +30% | +$665K | ﹤0.01% | 3130 |
|
|
2020
Q3 | $2.74M | Sell |
73,700
-32,400
| -31% | -$1.28M | ﹤0.01% | 2568 |
|
|
2020
Q2 | $5.44M | Buy |
+106,100
| New | +$4.44M | ﹤0.01% | 1753 |
|
|
2020
Q1 | – | Sell |
-11,200
| Closed | -$668K | – | 5461 |
|
|
2019
Q4 | $668K | Buy |
+11,200
| New | +$504K | ﹤0.01% | 3325 |
|
|
2018
Q4 | – | Sell |
-10,100
| Closed | -$448K | – | 5130 |
|
|
2018
Q3 | $448K | Buy |
+10,100
| New | +$464K | ﹤0.01% | 3744 |
|
|
2018
Q2 | – | Sell |
-7,300
| Closed | -$528K | – | 5106 |
|
|
2018
Q1 | $528K | Buy |
+7,300
| New | +$536K | ﹤0.01% | 3423 |
|
|
2017
Q4 | – | Sell |
-6,600
| Closed | -$331K | – | 4709 |
|
|
2017
Q3 | $331K | Sell |
6,600
-5,800
| -47% | -$280K | ﹤0.01% | 3567 |
|
|
2017
Q2 | $574K | Sell |
12,400
-16,300
| -57% | -$599K | ﹤0.01% | 2849 |
|
|
2017
Q1 | $1.01M | Buy |
+28,700
| New | +$657K | ﹤0.01% | 2058 |
|
Other funds holding ESPR
WA
TSC
O
VCM
